Elevated levels of Hs-CRP and IL-6 after delivery are associated with depression during the 6 months post partum

Psychiatry Research

Volumn 243, Issue , 2016, Pages 43-48

  Liu, Hao ^a   Zhang, Yang ^a   Gao, Yutao ^a   Zhang, Zhenyu ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Chinese; Depression; Hs CRP; IL 6; Postpartum

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; BIOLOGICAL MARKER; IL6 PROTEIN, HUMAN;

ADULT; ARTICLE; CHINESE; CLINICAL ARTICLE; DISEASE SEVERITY; EDINBURGH POSTNATAL DEPRESSION SCALE; FEMALE; FOLLOW UP; HUMAN; PRIORITY JOURNAL; PUERPERAL DEPRESSION; RECEIVER OPERATING CHARACTERISTIC; SCREENING; SENSITIVITY AND SPECIFICITY; BLOOD; CROSS-SECTIONAL STUDY; DEPRESSION, POSTPARTUM; HOSPITALIZATION; METABOLISM; OBSTETRIC DELIVERY; PREGNANCY; PSYCHOLOGY; TIME FACTOR; TRENDS;

ADULT; BIOMARKERS; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; DELIVERY, OBSTETRIC; DEPRESSION, POSTPARTUM; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; INTERLEUKIN-6; PREGNANCY; TIME FACTORS;

EID: 84976448200     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2016.02.022     Document Type: Article

References (39)

1. Albacar, G., Sans, T., Martín-Santos, R., García-Esteve, L., Guillamat, R., Sanjuan, J., et al. Thyroid function 48 h after delivery as a marker for subsequent postpartum depression. Psychoneuroendocrinology 35:5 (2010), 738–742.
2. Albacar, G., Sans, T., Martín-Santos, R., García-Esteve, L., Guillamat, R., Sanjuan, J., et al. An association between plasma ferritin concentrations measured 48 h after delivery and postpartum depression. J. Affect. Disord. 131:1 (2011), 136–142.
3. Bloch, M., Rotenberg, N., Koren, D., Klein, E., Risk factors for early postpartum depressive symptoms. Gen. Hosp. Psychiatry 28:1 (2006), 3–8.
4. Bremmer, M.A., Beekman, A.T.F., Deeg, D.J.H., Penninx, B.W.J.H., Dik, M.G., Hack, C.E., et al. Inflammatory markers in late-life depression: results from a population-based study. J. Affect. Disord. 106:3 (2008), 249–255.
5. Capuron, L., Gumnick, J.F., Musselman, D.L., Lawson, D.H., Reemsnyder, A., Nemeroff, C.B., et al. Neurobehavioral effects of interferon-α in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology 2002:26 (2002), 643–652.
6. Cassidy-Bushrow, A.E., Peters, R.M., Johnson, D.A., Templin, T.N., Association of depressive symptoms with inflammatory biomarkers among pregnant African-American women. J. Reprod. Immunol. 94:2 (2012), 202–209.
7. Corwin, E.J., Johnston, N., Pugh, L., Symptoms of postpartum depression associated with elevated levels of interleukin-1 beta during the first month postpartum. Biol. Res. Nurs. 10:2 (2008), 128–133.
8. Danese, A., Moffitt, T.E., Pariante, C.M., Ambler, A., Poulton, R., Caspi, A., Elevated inflammation levels in depressed adults with a history of childhood maltreatment. Arch. Gen. Psychiatry 65:4 (2008), 409–415.
9. Dantzer, R., O'Connor, J.C., Freund, G.G., Johnson, R.W., Kelley, K.W., From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 9:1 (2008), 46–56.
10. Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E.K., et al. A meta-analysis of cytokines in major depression. Biol. Psychiatry 67:5 (2010), 446–457.
11. Fu, C.W., Liu, J.T., Tu, W.J., Yang, J.Q., Cao, Y., Association between serum 25‐hydroxyvitamin D levels measured 24 hours after delivery and postpartum depression. BJOG: Int. J. Obstet. Gynaecol. 122:12 (2015), 1688–1694.
12. Gavin, N.I., Gaynes, B.N., Lohr, K.N., Meltzer-Brody, S., Gartlehner, G., Swinson, T., Perinatal depression: a systematic review of prevalence and incidence. Obstet. Gynecol. 106:5, Part 1 (2005), 1071–1083.
13. Gimeno, D., Kivimäki, M., Brunner, E.J., Elovainio, M., De Vogli, R., Steptoe, A., et al. Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study. Psychol. Med. 39:3 (2009), 413–423.
14. Halbreich, U., Karkun, S., Cross-cultural and social diversity of prevalence of postpartum depression and depressive symptoms. J. Affect. Disord. 91:2 (2006), 97–111.
15. Hannestad, J., DellaGioia, N., Bloch, M., The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology 36:12 (2011), 2452–2459.
16. Howren, M.B., Lamkin, D.M., Suls, J., Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom. Med. 71:2 (2009), 171–186.
17. Janssen, P.A., Heaman, M.I., Urquia, M.L., O'Campo, P.J., Thiessen, K.R., Risk factors for postpartum depression among abused and nonabused women. Am. J. obstet. Gynecol., 207(6), 2012 489-e1.
18. Josefsson, A., Angelsiöö, L., Berg, G., Ekström, C.M., Gunnervik, C., Nordin, C., Sydsjö, G., Obstetric, somatic, and demographic risk factors for postpartum depressive symptoms. Obstet. Gynecol. 99:2 (2002), 223–228.
19. Khairova, R.A., Machado-Vieira, R., Du, J., Manji, H.K., A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder. Int. J. Neuropsychopharmacol. 12:4 (2009), 561–578.
20. Khandaker, G.M., Pearson, R.M., Zammit, S., Lewis, G., Jones, P.B., Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study. JAMA Psychiatry 71:10 (2014), 1121–1128.
21. Knuth, B., Radtke, V., Rocha, P., Silva, K.S., Dalsóglio, F., Gazal, M., et al. Prevalence of depression symptoms and serum levels of interleukin‐6 in hemodialysis patients. Psychiatry Clin. Neurosci. 68:4 (2014), 275–282.
22. Krogh, J., Benros, M.E., Jørgensen, M.B., Vesterager, L., Elfving, B., Nordentoft, M., The association between depressive symptoms, cognitive function, and inflammation in major depression. Brain Behav. Immunity 35 (2014), 70–76.
23. LaCoursiere, D.Y., Barrett‐Connor, E., O'Hara, M.W., Hutton, A., Varner, M.W., The association between prepregnancy obesity and screening positive for postpartum depression. BJOG: Int. J. Obstet. Gynaecol. 117:8 (2010), 1011–1018.
24. Lanes, A., Kuk, J.L., Tamim, H., Prevalence and characteristics of postpartum depression symptomatology among Canadian women: a cross-sectional study. BMC Public Health, 11(1), 2011, 302.
25. Li, L., Liu, F., Zhang, H., Wang, L., Chen, X., Chinese version of the Postpartum Depression Screening Scale: translation and validation. Nurs. Res. 60:4 (2011), 231–239.
26. Liu, Y., Ho, R.C.M., Mak, A., Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression. J. Affect. Disord. 139:3 (2012), 230–239.
27. Loftis, J.M., Huckans, M., Morasco, B.J., Neuroimmune mechanisms of cytokine-induced depression: current theories and novel treatment strategies. Neurobiol. Dis. 37:3 (2010), 519–533.
28. Lopresti, A.L., Maker, G.L., Hood, S.D., Drummond, P.D., A review of peripheral biomarkers in major depression: the potential of inflammatory and oxidative stress biomarkers. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 48 (2014), 102–111.
29. Marques, A.H., Cizza, G., Sternberg, E., Brain-immune interactions and implications in psychiatric disorders. Rev. Bras. Psiquiatr. 29 (2007), s27–s32.
30. Milgrom, J., Gemmill, A.W., Bilszta, J.L., Hayes, B., Barnett, B., Brooks, J., Buist, A., Antenatal risk factors for postnatal depression: a large prospective study. J. Affect. Disord. 108:1 (2008), 147–157.
31. Pasco, J.A., Nicholson, G.C., Williams, L.J., Jacka, F.N., Henry, M.J., Kotowicz, M.A., et al. Association of high-sensitivity C-reactive protein with de novo major depression. Br. J. Psychiatry 197:5 (2010), 372–377.
32. Pearlstein, T., Howard, M., Salisbury, A., Zlotnick, C., Postpartum depression. Am. J. Obstet. Gynecol. 200:4 (2009), 357–364.
33. Reichlin, S., Neuroendocrine-immune interactions. N. Engl. J. Med. 329:17 (1993), 1246–1253.
34. Schiepers, O.J., Wichers, M.C., Maes, M., Cytokines and major depression. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 29:2 (2005), 201–217.
35. Skalkidou, A., Hellgren, C., Comasco, E., Sylvén, S., Sundström Poromaa, I., Biological aspects of postpartum depression. Women's Health 8:6 (2012), 659–671.
36. Sluzewska, A., Rybakowski, J., Bosmans, E., Sobieska, M., Berghmans, R., Maes, M., Wiktorowicz, K., Indicators of immune activation in major depression. Psychiatry Res. 64:3 (1996), 161–167.
37. Sylvén, S.M., Papadopoulos, F.C., Olovsson, M., Ekselius, L., Poromaa, I.S., Skalkidou, A., Seasonality patterns in postpartum depression. Am. J. Obstet. Gynecol., 204(5), 2011, 413 e1-6.
38. Thomas, A.J., Davis, S., Morris, C., Jackson, E., Harrison, R., O'Brien, J.T., Increase in interleukin-1β in late-life depression. Am. J. Psychiatry 162:1 (2005), 175–177.
39. Valkanova, V., Ebmeier, K.P., Allan, C.L., CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies. J. Affect. Disord. 150:3 (2013), 736–744.